STOCK TITAN

Medtronic appoints Thierry Piéton as Chief Financial Officer

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
management

Medtronic (NYSE: MDT) has appointed Thierry Piéton as Chief Financial Officer, effective March 3, 2025. Piéton, who joins from Renault Group where he served as CFO since March 2022, will report to Chairman and CEO Geoff Martha and join the Executive Committee.

Under Piéton's leadership at Renault, the company achieved record operating margins and improved free cash flow, while executing portfolio management through acquisitions, divestitures, and innovative partnerships. His experience spans healthcare and regulated manufacturing industries, including roles at Nissan Motor, General Electric, GE Healthcare, and PricewaterhouseCoopers.

Gary Corona, who has been serving as interim CFO, will transition to Senior Vice President, Corporate Finance and remain on the Executive Committee. During Corona's interim tenure, Medtronic delivered revenue growth and exceeded EPS expectations in the first and second quarters.

Medtronic (NYSE: MDT) ha nominato Thierry Piéton come Chief Financial Officer, con effetto dal 3 marzo 2025. Piéton, che proviene dal Groupe Renault dove ha ricoperto il ruolo di CFO da marzo 2022, riporterà al Presidente e CEO Geoff Martha e entrerà a far parte del Comitato Esecutivo.

Sotto la guida di Piéton in Renault, l'azienda ha raggiunto margini operativi record e migliorato il flusso di cassa libero, mentre gestiva il portafoglio attraverso acquisizioni, dismissioni e partnership innovative. La sua esperienza spazia tra i settori della sanità e della produzione regolamentata, includendo ruoli presso Nissan Motor, General Electric, GE Healthcare e PricewaterhouseCoopers.

Gary Corona, che ha servito come CFO ad interim, passerà a Vicepresidente Senior, Finanza Aziendale e rimarrà nel Comitato Esecutivo. Durante il mandato ad interim di Corona, Medtronic ha registrato una crescita dei ricavi e ha superato le aspettative sugli utili per azione nel primo e secondo trimestre.

Medtronic (NYSE: MDT) ha nombrado a Thierry Piéton como Director Financiero, con efecto a partir del 3 de marzo de 2025. Piéton, quien proviene del Grupo Renault donde se desempeñó como CFO desde marzo de 2022, reportará al Presidente y CEO Geoff Martha y se unirá al Comité Ejecutivo.

Bajo el liderazgo de Piéton en Renault, la compañía alcanzó márgenes operativos récord y mejoró el flujo de caja libre, mientras gestionaba su cartera a través de adquisiciones, desinversiones y asociaciones innovadoras. Su experiencia abarca las industrias de atención médica y manufactura regulada, incluyendo roles en Nissan Motor, General Electric, GE Healthcare y PricewaterhouseCoopers.

Gary Corona, quien ha estado sirviendo como CFO interino, pasará a ser Vicepresidente Senior de Finanzas Corporativas y permanecerá en el Comité Ejecutivo. Durante el mandato interino de Corona, Medtronic logró un crecimiento en sus ingresos y superó las expectativas de EPS en el primer y segundo trimestres.

메드트로닉 (NYSE: MDT)는 티에리 피에톤을 2025년 3월 3일부터 최고재무책임자(CFO)로 임명했습니다. 피에톤은 2022년 3월부터 CFO로 재직했던 르노 그룹에서 합류하며, 회장 겸 CEO인 제프 마사에게 보고하고 집행위원회에 참여할 것입니다.

피에톤의 리더십 아래에서 르노는 기록적인 운영 마진을 달성하고 자유 현금을 개선했으며, 인수, 매각 및 혁신적인 파트너십을 통해 포트폴리오 관리에 나섰습니다. 그의 경험은 의료 및 규제 제조 산업을 아우르며, 닛산 자동차, 제너럴 일렉트릭, GE 헬스케어, 프라이스워터하우스쿠퍼스에서의 역할을 포함합니다.

김 코로나는 임시 CFO로 재직 중, 수석 부사장인 기업 재무로 전환되어 집행위원회에 남게 됩니다. 코로나의 임시 재임 기간 동안 메드트로닉은 수익 성장과 첫 두 분기 동안 EPS 기대치를 초과 달성했습니다.

Medtronic (NYSE: MDT) a nommé Thierry Piéton au poste de Chief Financial Officer, à compter du 3 mars 2025. Piéton, qui vient du groupe Renault où il a été CFO depuis mars 2022, rendra compte au président et CEO Geoff Martha et rejoindra le comité exécutif.

Sous la direction de Piéton chez Renault, l'entreprise a atteint des marges opérationnelles record et amélioré son flux de trésorerie libre, tout en gérant son portefeuille par le biais d'acquisitions, de cessions et de partenariats innovants. Son expérience couvre les secteurs de la santé et de la fabrication régulée, y compris des fonctions chez Nissan Motor, General Electric, GE Healthcare et PricewaterhouseCoopers.

Gary Corona, qui a occupé le poste de CFO par intérim, passera au poste de vice-président senior, finances d'entreprise et restera au sein du comité exécutif. Pendant le mandat intérimaire de Corona, Medtronic a enregistré une croissance des revenus et a dépassé les attentes en matière de bénéfices par action au cours des premier et deuxième trimestres.

Medtronic (NYSE: MDT) hat Thierry Piéton zum Chief Financial Officer ernannt, ab dem 3. März 2025. Piéton, der zuvor als CFO der Renault-Gruppe seit März 2022 tätig war, wird an den Vorstandsvorsitzenden und CEO Geoff Martha berichten und dem Exekutivkomitee beitreten.

Unter Piétons Führung bei Renault erzielte das Unternehmen Rekordbetriebsgewinne und verbesserte den freien Cashflow, während es das Portfolio durch Übernahmen, Veräußern und innovative Partnerschaften verwaltete. Seine Erfahrung erstreckt sich über die Gesundheits- und regulierte Fertigungsindustrie, einschließlich Rollen bei Nissan Motor, General Electric, GE Healthcare und PricewaterhouseCoopers.

Gary Corona, der als Interim CFO tätig war, wird zum Senior Vice President, Corporate Finance wechseln und im Exekutivkomitee bleiben. Während Coronas interimistischer Amtszeit erzielte Medtronic Einnahmenwachstum und übertraf die EPS-Erwartungen im ersten und zweiten Quartal.

Positive
  • Appointment of experienced CFO with proven track record in margin improvement
  • New CFO's background includes relevant healthcare industry experience
  • Company exceeded revenue and EPS expectations in recent quarters
Negative
  • None.

GALWAY, Ireland, Jan. 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Thierry Piéton has been appointed Chief Financial Officer for the company, effective March 3, 2025. He will report to Medtronic Chairman and Chief Executive Officer Geoff Martha and will join the Medtronic Executive Committee. Piéton joins Medtronic from Renault Group, where he has served as Chief Financial Officer since March 2022. Gary Corona, who has been serving as interim CFO, will continue in this role until Piéton joins Medtronic, after which Corona will become Senior Vice President, Corporate Finance and will remain on the Medtronic Executive Committee.

"Thierry is a strategic, creative, operationally focused, experienced CFO with a proven track record of delivering innovation-driven growth, margin improvement, and earnings power through strong financial leadership, which is directly aligned with our financial objectives," said Geoff Martha, Medtronic chairman and chief executive officer. "We are confident he is the right choice at this important time for Medtronic and can't wait to benefit from his expertise and leadership."

Under Piéton's leadership, Renault achieved its highest ever operating margins and improved free cash flow, while also executing portfolio management, including tuck-in acquisitions, divestitures, and funding development through innovative partnerships. This led to significant value creation for its shareholders. Piéton brings experience in both healthcare and other highly regulated, operationally focused manufacturing companies, including Nissan Motor Co. Ltd, General Electric, GE Healthcare and PricewaterhouseCoopers. His career path to CFO demonstrates intentional development through accretive experiences across several industries, geographies, companies, and all facets of a global finance function.

As CFO, Piéton will be responsible for leading the Medtronic global finance organization and key supporting functions, including Treasury, Controller, Tax, Internal Audit, Investor Relations, Corporate Strategy, and Business Development.

"I also want to recognize Gary Corona, who has served as interim CFO. Gary helped us deliver revenue growth and EPS that exceeded expectations in our first and second quarters and has provided strong leadership of our Finance function over the last six months. He will help ensure a smooth and successful transition, and I look forward to continuing to work with him in his new role leading several key Corporate finance functions," said Martha.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit www.Medtronic.com and follow Medtronic on LinkedIn

Contacts:


Erika Winkels

 Ryan Weispfenning

Public Relations

Investor Relations

+1-763-526-8478

+1-763-505-4626

 

(PRNewsfoto/Medtronic plc)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-appoints-thierry-pieton-as-chief-financial-officer-302355770.html

SOURCE Medtronic plc

FAQ

When will Thierry Piéton start as Medtronic's (MDT) new CFO?

Thierry Piéton will start as Medtronic's CFO on March 3, 2025.

What was Thierry Piéton's previous role before joining MDT?

Piéton served as Chief Financial Officer at Renault Group since March 2022.

What achievements did Piéton accomplish at Renault before joining MDT?

Under Piéton's leadership, Renault achieved its highest ever operating margins, improved free cash flow, and executed portfolio management including acquisitions and divestitures.

What will happen to Medtronic's interim CFO Gary Corona?

Gary Corona will become Senior Vice President, Corporate Finance and remain on the Medtronic Executive Committee.

What will be Thierry Piéton's responsibilities at MDT?

Piéton will lead Medtronic's global finance organization and key functions including Treasury, Controller, Tax, Internal Audit, Investor Relations, Corporate Strategy, and Business Development.

Medtronic plc

NYSE:MDT

MDT Rankings

MDT Latest News

MDT Stock Data

113.52B
1.28B
0.26%
85.42%
0.79%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
GALWAY